AOD-9604: FDA status and clinical evidence

Not FDA-approved

AOD-9604 is not approved by the FDA and has no studies registered on ClinicalTrials.gov as an intervention.

FDA-approved

Registered studies

None

Highest phase

FDA applications

FDA approval status

Status

No approved application

Clinical evidence

No study registered on ClinicalTrials.gov lists AOD-9604 as an intervention. Registration is required for most human trials in the US, so an absence here means research has not been formally registered, not that results are merely unpublished.

Full trial breakdown for AOD-9604 →

Molecular identity

Substance class

Protein

FDA UNII

7UP768IP4M

CAS number

221231-10-3

Amino acid sequence

YLRIVQCRSVEGSCGF

Sequence length

16 residues

Molecular weight

1820 g/mol

Recorded synonyms

From the FDA Global Substance Registration System, the registry that assigns every substance the FDA tracks a unique identifier.

How to read this. This page reports what federal records say about AOD-9604, nothing more. An FDA approval covers specific uses and doses on a reviewed label. A registered trial records that research was declared, not that it succeeded. A listed patent governs who may sell a drug, not whether it works. None of this is medical advice, and none of it means a compound is safe to use outside a prescription.

Frequently asked questions

Is AOD-9604 FDA-approved?

No. There is no FDA application for AOD-9604 and no registered clinical trial listing it as an intervention.

Why are there no clinical trials for AOD-9604?

Most human research in the US must be registered before it begins. No registration for AOD-9604 means no formal trial has been declared. Laboratory and animal work can still exist, and does not appear in this registry.

Where does the information on this page come from?

Four FDA and NIH sources: Drugs@FDA for approval records, the FDA Orange Book for patents and exclusivity, the FDA Global Substance Registration System for molecular identity, and ClinicalTrials.gov for trial counts. Each is refreshed on a schedule and the date above shows the last refresh.

Sources: Drugs@FDA, FDA Orange Book, FDA Global Substance Registration System and ClinicalTrials.gov. Last refreshed 2026-10-16.